{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:44:08Z","timestamp":1793321048433,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0008834","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000}}],"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"T\u00dcB\u0130TAK","award":["115S076"],"award-info":[{"award-number":["115S076"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne virus in the <jats:italic>Nairoviridae<\/jats:italic> family within the <jats:italic>Bunyavirales<\/jats:italic> order of viruses. Crimean-Congo hemorrhagic fever (CCHF) is the most widespread among tick-borne human viral diseases. It is endemic in many areas of Africa, Asia, the Middle East, in the Balkans, Russia and countries of the former Soviet Union. The confirmed CCHF cases were seen in Spain in 2016 to signify expansion of the virus into new geographical areas. CCHFV causes a viral human disease characterized by sudden onset of fever, headache, abdominal pain, nausea, hypotension, hemorrhage, and hepatic dysfunction with fatality rates up to 30%. Currently, there are no spesific treatments or licensed vaccines available for CCHFV. The absence of a susceptible animal model for CCHFV infection was severely hindered work on the development of vaccines. However, several animal models of CCHFV infection have been recently developed and used to assess vaccine efficacy. In this study, we have used the transiently immune-suppressed (IS) mouse model that MAb-5A3 was used to block IFN-I signaling in immune intact, wild-type mice at the time of CCHFV infection to evaluate the immune response and efficacy of the cell culture based and the mouse brain derived inactivated vaccines against CCHFV. Both vaccine preparations have provided complete protection but the cell culture based vaccine more effectively induced to CCFHV spesific antibodies and T cell responses. This is the first comparison of the cell culture based and the mouse brain derived vaccines for assessing the protective efficacy and the immunogenicity in the IS mouse CCHFV model.<\/jats:p>","DOI":"10.1371\/journal.pntd.0008834","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T19:47:11Z","timestamp":1606160831000},"page":"e0008834","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7178-0943","authenticated-orcid":true,"given":"Shaikh Terkis Islam","family":"Pavel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-791X","authenticated-orcid":true,"given":"Hazel","family":"Yetiskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9452-1031","authenticated-orcid":true,"given":"Ahmet","family":"Kalkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6950-8545","authenticated-orcid":true,"given":"Aykut","family":"Ozdarendeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"issue":"4","key":"pntd.0008834.ref001","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","article-title":"Crimean-Congo haemorrhagic fever","volume":"6","author":"O Ergonul","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"pntd.0008834.ref002","first-page":"1741","author":"CS Schmaljohn","year":"2007","edition":"5"},{"issue":"1","key":"pntd.0008834.ref003","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","article-title":"Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity","volume":"100","author":"DA Bente","year":"2013","journal-title":"Antiviral Res"},{"key":"pntd.0008834.ref004","first-page":"F1000","article-title":"Recent advances in understanding Crimean-Congo hemorrhagic fever virus. F1000Res","volume":"7","author":"DW Hawman","year":"2018","journal-title":"Faculty Rev-1715"},{"issue":"4","key":"pntd.0008834.ref005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jmedent\/15.4.307","article-title":"The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa","volume":"15","author":"H Hoogstraal","year":"1979","journal-title":"J Med Entomol"},{"issue":"5","key":"pntd.0008834.ref006","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/QCO.0b013e3282a56a0a","article-title":"Crimean-Congo hemorrhagic fever","volume":"20","author":"R Vorou","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"pntd.0008834.ref007","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2016.09.013","article-title":"A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus","volume":"135","author":"JR Spengler","year":"2016","journal-title":"Antiviral Res"},{"key":"pntd.0008834.ref008","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.coviro.2018.12.002","article-title":"Crimean-Congo hemorrhagic fever and expansion from endemic regions","volume":"34","author":"JR Spengler","year":"2019","journal-title":"Curr Opin Virol"},{"issue":"7","key":"pntd.0008834.ref009","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/v11070590","article-title":"Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease","volume":"11","author":"AR Garrison","year":"2019","journal-title":"Viruses"},{"issue":"21","key":"pntd.0008834.ref010","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1128\/JVI.01383-10","article-title":"Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model","volume":"84","author":"DA Bente","year":"2010","journal-title":"J Virol"},{"issue":"6","key":"pntd.0008834.ref011","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1099\/vir.0.019034-0","article-title":"Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice","volume":"91","author":"S Bereczky","year":"2010","journal-title":"J Gen Virol"},{"issue":"11","key":"pntd.0008834.ref012","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/infdis\/jix215","article-title":"Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection","volume":"216","author":"JR Spengler","year":"2017","journal-title":"J Infect Dis"},{"issue":"9","key":"pntd.0008834.ref013","doi-asserted-by":"crossref","first-page":"e0005908","DOI":"10.1371\/journal.pntd.0005908","article-title":"A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models","volume":"11","author":"AR Garrison","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0008834.ref014","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41564-018-0141-7","article-title":"A cynomolgus macaque model for Crimean-Congo haemorrhagic fever","volume":"3","author":"E Haddock","year":"2018","journal-title":"Nat Microbiol"},{"issue":"3","key":"pntd.0008834.ref015","doi-asserted-by":"crossref","first-page":"e91516","DOI":"10.1371\/journal.pone.0091516","article-title":"A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model","volume":"9","author":"KR Buttigieg","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"pntd.0008834.ref016","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1128\/CVI.05352-11","article-title":"Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus","volume":"18","author":"SM Ghiasi","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"12","key":"pntd.0008834.ref017","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/vbz.2015.1855","article-title":"Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice","volume":"15","author":"J Kortekaas","year":"2015","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"3","key":"pntd.0008834.ref018","doi-asserted-by":"crossref","first-page":"e0003579","DOI":"10.1371\/journal.pntd.0003579","article-title":"Immunization of knock-out alpha\/beta interferon receptor mice against high lethal dose of Crimean-Congo hemorrhagic fever virus with a cell culture based vaccine","volume":"9","author":"N Canakoglu","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0008834.ref019","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/22221751.2019.1601030","article-title":"Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice","volume":"8","author":"FM Scholte","year":"2019","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"pntd.0008834.ref020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/21645515.2015.1078045","article-title":"A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease","volume":"12","author":"SD Dowall","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"pntd.0008834.ref021","doi-asserted-by":"crossref","first-page":"e0156637","DOI":"10.1371\/journal.pone.0156637","article-title":"Protective effects of a modified vaccinia Ankara-based vaccine candidate against Crimean-Congo haemorrhagic fever virus requires both cellular and humoral immune responses","volume":"11","author":"SD Dowall","year":"2016","journal-title":"PLOS One"},{"issue":"1","key":"pntd.0008834.ref022","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/v11010075","article-title":"Co-Delivery Effect of CD24 on the Immunogenicity and Lethal Challenge Protection of a DNA Vector Expressing Nucleocapsid Protein of Crimean Congo Hemorrhagic Fever Virus","volume":"11","author":"FT Aligholipour","year":"2019","journal-title":"Viruses"},{"issue":"3","key":"pntd.0008834.ref023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/vaccines7030115","article-title":"Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models","volume":"7","author":"FT Aligholipour","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"pntd.0008834.ref024","doi-asserted-by":"crossref","first-page":"e02076","DOI":"10.1128\/JVI.02076-16","article-title":"Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and\/or Virus-Like Particles Induces Protection and Survival in Challenged Mice","volume":"91","author":"J Hinkula","year":"2017","journal-title":"J Virol"},{"issue":"1","key":"pntd.0008834.ref025","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.1038\/s41598-019-44210-6","article-title":"Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever","volume":"9","author":"SE Rodriguez","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"pntd.0008834.ref026","doi-asserted-by":"crossref","first-page":"e0006628","DOI":"10.1371\/journal.pntd.0006628","article-title":"Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge","volume":"12","author":"M Zivcec","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008834.ref027","first-page":"7","article-title":"Vaccine against Congo-Crimean haemorhagic fever virus-Bulgarian input in fighting the disease","volume":"37","author":"I Christova","year":"2010","journal-title":"Probl Infect Parasit Dis"},{"issue":"2","key":"pntd.0008834.ref028","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2011.02.010","article-title":"Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies","volume":"90","author":"M Keshtkar-Jahromi","year":"2011","journal-title":"Antiviral research"},{"issue":"3","key":"pntd.0008834.ref029","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/00365548.2010.540036","article-title":"The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain","volume":"43","author":"A Papa","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"pntd.0008834.ref030","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1016\/j.vaccine.2012.08.003","article-title":"Healthy individuals\u2019 immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine","volume":"30","author":"M Mousavi-Jazi","year":"2012","journal-title":"Vaccine"},{"key":"pntd.0008834.ref031","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.virusres.2009.11.009","article-title":"The complete genome analysis of Crimean-Congo hemorrhagic fever virus isolated in Turkey","volume":"147","author":"A Ozdarendeli","year":"2010","journal-title":"Virus Res"},{"key":"pntd.0008834.ref032","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jviromet.2012.07.025","article-title":"Application of the pseudo-plaque assay for detection and titration of Crimean-Congo hemorrhagic fever virus","volume":"187","author":"E Berber","year":"2012","journal-title":"J Virol Methods"},{"key":"pntd.0008834.ref033","first-page":"10","article-title":"Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus","volume":"3","author":"N Canakoglu","year":"2013","journal-title":"Virol J"},{"key":"pntd.0008834.ref034","article-title":"2018 Annual review of diseases prioritized under the Research and Development Blueprint","author":"WHO","year":"2018"},{"key":"pntd.0008834.ref035","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1016\/j.vaccine.2017.05.031","article-title":"Development of vaccines against Crimean-Congo haemorrhagic fever virus","volume":"35","author":"SD Dowall","year":"2017","journal-title":"Vaccine"},{"key":"pntd.0008834.ref036","author":"M Sahib M","year":"2010"},{"issue":"10","key":"pntd.0008834.ref037","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.vaccine.2010.12.038","article-title":"Comparison of viral glycosylation using lectin blotting with Vero cell-derived and mouse brain-derived Japanese encephalitis vaccines","volume":"29","author":"H Toriniwa","year":"2011","journal-title":"Vaccine"},{"key":"pntd.0008834.ref038","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1128\/JVI.79.10.6152-6161.2005","article-title":"Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins","volume":"79","author":"A Bertolotti-Ciarlet","year":"2005","journal-title":"J Virol"},{"issue":"7","key":"pntd.0008834.ref039","doi-asserted-by":"crossref","first-page":"eaaw9535","DOI":"10.1126\/sciadv.aaw9535","article-title":"GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection","volume":"5","author":"JW Golden","year":"2019","journal-title":"Sci Adv"},{"key":"pntd.0008834.ref040","doi-asserted-by":"crossref","first-page":"e00554","DOI":"10.1128\/JVI.00554-19","article-title":"Crimean-Congo hemorrhagic fever mouse model recapitulating human convalescence","volume":"93","author":"DW Hawman","year":"2019","journal-title":"J Virol"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0008834","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T23:30:25Z","timestamp":1607383825000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008834"}},"subtitle":[],"editor":[{"given":"Dennis A.","family":"Bente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008834","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0008834","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]}}}